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Abstract 
Photodynamic therapy (PDT) is an emerging cancer therapy that utilizes photoactive drug 
molecules, which can be activated with low energy light but are otherwise inactive. Previous 
studies show that ruthenium(II) complexes with ancillary nitrile ligands are a promising tool in 
PDT due to their rapid photodissociative properties, which allows for selective delivery of 
therapeutic agents.[1] If the dissociative nature of this bond can be tuned, these compounds could 
serve in the development of novel oncological treatments. This study aims to analyze the effects 
of various bidentate ligands on the bond strength of acetonitrile bound to a ruthenium(II) metal 
center and to determine which parameters most account for efficient nitrile ligand loss. A series 
of six ruthenium(II)-polypyridyl complexes, each with a different bipyridyl derivative, were 
subjected to singlet and triplet state geometry optimizations using B3LYP functional and a 
combination of the 6-31G* and SDD basis sets. The Mayer bond orders and bond lengths of the 
nitrile bond and the percent metal character in each derivative were calculated and compared to 
assess which bidentate ligand results in the greatest destabilization of the acetonitrile bond. It 
was determined that nitrile ligand loss occurs from the triplet state, and that complexes with 
more metal-centered character in the excited state will likely undergo more efficient nitrile 
ligand loss, but further studies are required. 
 
Introduction 
Currently, one of the most effective anticancer agents for a wide variety of cancers is cisplatin, 
cis-[Pt(NH3)Cl2], and its derivatives.[2-7] Upon entering the cell, cisplatin is activated, at which 
point it exchanges both chloride ligands for two water molecules. In its hydrated form, the 
molecule can bind to the DNA bases causing irreparable damage, interrupting cell reproduction 
and triggering cell death. The process by which the chloride and water exchange occurs is 
induced thermally, which allows the drug to be targeted at rapidly reproducing cells.[5-7] But this 
treatment is nonspecific; many healthy cells in the body, such as liver and hair cells, also 
reproduce quickly. These healthy cells are attacked by the cisplatin, leading to varying 
undesirable and potentially life-threatening side effects.[6-7] Furthermore, cisplatin only shows 
specificity for certain types of cancer, such as ovarian or testicular cancer, limiting its versatility. 
The more aggressive cancers that it does treat effectively, like breast cancer, are known to 
develop a resistance to the drug, complicating treatment in the event of a recurrence.[2-7]  
 
To avoid the adverse effects related to cisplatin-based treatments, novel oncological methods are 
being explored. Currently, photodynamic therapy (PDT) is at the forefront of these new FDA-
approved techniques. Drug molecules involved in PDT are otherwise nontoxic until activated by 
excitation with low energy visible light.[8-10] Able to permeate up to 2 cm of skin, low energy 
visible light (ca. 600-900 nm) is an optimal choice for activation of these drug molecules in most 
bodily tissue, including cells, membranes, or in proximity of the tumor, allowing for general 
localization to the cancerous area.  
 
Ru(II)-polypyridyl complexes have been extensively studied for the past several decades for their 
novel electro- and photochemical properties. Their high extinction coefficients and long-lived 
excited states give rise to an increased probability of electronic excitation and resulting 
photochemical transitions, producing unique reaction possibilities.[11] Furthermore, they are well-
known to undergo rapid photoinduced nitrile ligand dissociation.[12-15] When irradiated with low 
energy visible light, the complex is excited from the 1GS (singlet ground state) to a high energy 
1MLCT (singlet metal-to-ligand charge transfer) state, quickly undergoing intersystem crossing 
to the 3MLCT (triplet metal-to-ligand charge transfer) state with unity quantum yield. At this 
point, the 3MC (triplet metal centered) state is available for thermal population, allowing for 
ligand dissociation.[16] The capability of Ru(II) compounds to undergo excited state ligand loss 
makes them ideal models for improving PDT, as they allow for specific photoactivated delivery 
of bound therapeutic molecules. 
 
Density Functional Theory (DFT) is a computational quantum mechanical modeling method by 
which these potential Ru(II) complexes can be theoretically optimized and studied, providing a 
method to rationally design new and effective Ru(II)-based PDT agents. DFT utilizes the 
variational principle – a method by which to find functions that optimize quantities dependent on 
those functions – to sift through all eligible wavefuctions in order to select a subset from which 
to then systematically minimize the energy functional E[Ψ], optimizing the single point energy 
of the molecule.[17]  
 
When the initial structure is input into the program, the initial system is perturbed by changing 
the atom position. Then, the wavefunction at the new atom position is recalculated and the new 
single point energy of the molecule is determined. If the energy of the perturbed structure is 
higher than that of the initial structure, the molecule is returned to its original structure and the 
perturbation cycle begins again, now changing the system in a different manner. If the new 
energy is lower, however, the perturbed structure is kept and cycled through again. This process 
continues until a minimum is found, where each new round of perturbation results in increased 
single point energy of the molecule, indicated by the peaks shown in Figure 1. At this point, the 
system is considered optimized and the final structure is returned. After a structure is optimized, 
the second derivative of the output (Figure 1) is then calculated to ensure that the structure has 
reached an energy minimum and not a saddle point.  
 
Figure 1: Example output for an optimization calculation.  
 
 
Coupled with other calculation programs like AOMix, DFT becomes a powerful tool in 
determining the effect of an infinite number of parameters on the chemistry of a particular 
molecule. By studying a series of analogue molecules, especially in the context of empirical data 
and established trends, comparisons can be made to investigate exactly why a molecule exhibits 
a certain behavior, which in this study is nitrile ligand loss. If it can be determined which factors 
are responsible for a behavior, then that behavior can be tuned to optimize those properties. This 
ability of DFT makes it an invaluable device in the design of new molecules for PDT.  
 
The complexes under investigation are [Ru(tpy)(bpy)(NCCH3)]2+ (Bpy, 1; tpy = 2,2’:6’,2’’-
terpyridine, bpy = 2,2’-bipyridine), [Ru(tpy)(Mebpy)(NCCH3)]2+ (Mebpy, 2; mebpy = 6,6’-
dimethyl-2,2’-bipyridine), [Ru(tpy)(OTOpy)(NCCH3)]2+ (OTOpy, 3; OTOpy = 2-(pyridine-2-
yl)-1,3-O-oxathiane), [Ru(tpy)(OTSpy)(NCCH3)]2+ (OTSpy, 4; 2-(pyridine-2-yl)-1,3-S-
oxathiane), [Ru(tpy)(Acpy)(NCCH3)]+ (Acpy, 5; 2-pyridinecarboxylate), 
[Ru(tpy)(Thiopy)(NCCH3)]2+ (Thiopy, 6; Thiopy = 6-(2-thienyl)-pyrindine), and their molecular 
structures are shown in Figure 2. Complexes were investigated in pairs (1 and 2, 3 and 4, 5 and 
6) to better compare the nitrile ligand lability.  
 
Figure 2: The proposed complexes for study: (1) [Ru(tpy)(bpy)(NCCH3)]2+,  
(2) [Ru(tpy)(Mebpy)(NCCH3)]2+, (3) [Ru(tpy)(OTOpy)(NCCH3)]2+, (4) [Ru(tpy)(OTSpy)(NCCH3)]2+,  
(5) [Ru(tpy)(Acpy)(NCCH3)]+, and (6) [Ru(tpy)(Thiopy)(NCCH3)]2+. 
 
Experimental Methods 
All molecules were first subjected to loose and tight geometry optimizations. Then, force 
constant calculations were run to ensure that the optimized structures were not at energy saddle 
points (ΔE = 10-7 – 10-10). Frequency and time-dependent DFT analyses were also conducted to 
ensure the absence of imaginary frequencies or wavelengths. Finally, electron density plots were 
generated and Mayer bond orders, bond lengths, and percent metal character for each structure 
were calculated. 
 
DFT optimizations were run using B3LYP functional and 6-31g* for all non-metal atoms and the 
Stuttgart-Dresden energy-consistent pseudo-potential for the ruthenium atoms for the singlet and 
triplet states using Gaussian 09. Triplet state calculations were treated with UB3LYP, which 
analyzes the electron spins individually by dividing the orbitals, instead of forcing the electrons 
to be spin-paired as in B3LYP. AOMix was used to calculate Mayer bond orders, bond lengths, 
and percent fragment characters.  
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Results and Discussion 
The data suggests that ligand loss occurs from the triplet manifold of states through a process 
controlled by kinetics, as diagrammed in Figure 3.  
 
Figure 3: Jablonski Diagram of Ru(II)-polypyridyl excited state manifold where more 3MC character leads 
to more efficient ligand loss.  
 
The mechanism by which the nitrile ligand loss occurs (Figure 3) begins typically, with the 
initial 1MLCT excitation from the 1GS and rapid intersystem crossing to 3MLCT, which is 
expected to populate within 40 femtoseconds with unit efficiency.[18] From this state, the 3MC 
state is thermally accessible and elimination of the nitrile ligand becomes possible. It is expected 
that dissociation will occur from the 3MC state due to increased metal character in the excited 
state of the complexes, discussed later.  
 
Mayer bond order, which is an extension of the Wiberg bond order and Mulliken population 
analysis,[19] describes the covalency of the bond on a scale of zero to one with zero being most 
ionic and one being most covalent, and bond lengths were investigated initially, under the 
postulation that complexes containing longer and more ionic ruthenium-nitrile bonds would 
result in more efficient ligand loss. Under this assumption, the data presented in Table 1 would 
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then indicate that [Ru(tpy)(bpy)(NCCH3)]2+, [Ru(tpy)(OTOpy)(NCCH3)]2+, and 
[Ru(tpy)(Acpy)(NCCH3)]+ would all undergo more rapid ligand elimination because they have 
longer and more ionic bonds in the excited triplet state, as compared to the singlet ground state.  
However, it has been previously shown[16] that Ru(tpy)(Mebpy)(NCCH3)]2+ has a much lower 
3MC state than [Ru(tpy)(bpy)(NCCH3)]2+, and therefore undergoes more facile ligand loss, 
which is contrary to the bolded data, so this process is likely not controlled by bond distance or 
bond covalency. 
 
 
Table 1: Mayer bond orders and bond distances for the ruthenium-nitrile bond of each complex in both 
the singlet and triplet states. 
 
The electron density maps (Figures 4-9) and the percent fragment character data (Table 2) also 
suggest that the nitrile ligand loss occurs as a results of greater access to a low-lying 3MC state, 
resulting in favorable rates of ligand loss. 
Bpy Mebpy OTOpy OTSpy Acpy Thiopy 
State 1GS 3MC 1GS 3MC 1GS 3MC 1GS 3MC 1GS 3MC 1GS 3MC 
Mayer Bond Order 0.489 0.447 0.493 0.450 0.508 0.498 0.521 0.510 0.520 0.480 0.519 0.503 
Bond Distance 2.048 2.060 2.045 2.058 2.040 2.044 2.034 2.039 2.039 2.058 2.038 2.056 
 
Figure 4: Electron density maps of selected MO calculations of [Ru(tpy)(bpy)(NCCH3)]2+ (isoval=0.04). 
 
Figure 4 above shows the electron density plot for [Ru(tpy)(bpy)(NCCH3)]2+. The superimposed 
red and green surfaces indicate areas of electron density, with the different colors representing 
the two different electronic phases. The process diagrammed in Figure 3 can be followed through 
these maps. Beginning with the initial 1MLCT excitation from the 1GS in the singlet diagrams, 
the electron density shifts from the central ruthenium atom (HOMO) to the terpyridine ligand 
(LUMO), corresponding to a shift from a nonbonding dπ interaction to an antibonding π* 
interaction. The intersystem crossing to the 3MLCT state is then seen in the Triplet – α 
(HSOMO) diagram, where the density has transferred to the bipyridine ligand, which is also an 
antibonding π* interaction. The other compounds (Figures 5-9) follow similarly, though not all 
complexes show electron density movement during the intersystem crossing to the 3MLCT state, 
as the electron density remains on the terpyridine ligand during this electronic event for the 
OTOpy and OTSpy compounds. However, the more significant differences are in the amount of 
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density remaining on the ruthenium atom in the excited triplet manifold for each complex. For 
each complex pair, [Ru(tpy)(Mebpy)(NCCH3)]2+, [Ru(tpy)(OTOpy)(NCCH3)]2+, and 
[Ru(tpy)(Thiopy)(NCCH3)]2+ all show more ruthenium character in the excited triplet state, 
which is supported by the data presented in Table 2.  
 
 
Figure 5: Electron density maps of selected MO calculations of [Ru(tpy)(Mebpy)(NCCH3)]2+ (isoval=0.04). 
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Figure 6: Electron density maps of selected MO calculations of [Ru(tpy)(OTOpy)(NCCH3)]2+ (isoval=0.04). 
 
 
Figure 7: Electron density maps of selected MO calculations of [Ru(tpy)(OTSpy)(NCCH3)]2+ (isoval=0.04). 
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Figure 8: Electron density maps of selected MO calculations of [Ru(tpy)(Acpy)(NCCH3)]+ (isoval=0.04). 
 
 
Figure 9: Electron density maps of selected MO calculations of [Ru(tpy)(Thiopy)(NCCH3)]2+ (isoval=0.04). 
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Because these Ru(II) complexes are low-spin d6 pseudo-octahedral systems, inducing a 
photoexcited state requires promoting an electron from the completely filled t2g-like orbitals to 
the empty eg t2g-like orbitals. Promoting this electron means shifting electron density from a 
more stable nonbonding orbital to a less stable antibonding orbital. Moreover, the t2g-like orbitals 
lie between the xyz axes, whereas the two eg-like orbitals lie directly along the axes, so exciting 
an electron puts more electron density directly in conflict with the density on the central 
ruthenium atom, increasing the electron-electron repulsions. Taken together, these effects 
significantly destabilize the ruthenium-nitrile bond, reducing the activation energy for ligand loss 
and increasing the efficiency.  
 
These electronic effects suggest that complexes with more ruthenium character in the excited 
triplet state should then undergo more rapid nitrile ligand loss. This assertion is supported by the 
bolded data in Table 2, which shows the percent metal character in each state for all derivatives. 
 Table 2: Percent ruthenium and terpyridine character for selected MO calculations for each complex. 
The bolded data comparing Ru(tpy)(bpy)(NCCH3)]2+ and  [Ru(tpy)(Mebpy)(NCCH3)]2+ clearly 
indicates that the excited triplet manifold for [Ru(tpy)(Mebpy)(NCCH3)]2+ contains greater 
Ru(3MC) character than [Ru(tpy)(bpy)(NCCH3)]2+, meaning that under this assertion, the Mebpy 
complex should undergo more rapid nitrile ligand loss. This is supported by experimental data in 
which Turro and coworkers have previously shown through quantum yield studies that the 3MC 
state is more accessible for sterically bulky Ru(II)-polypyridyl complexes, with the quantum 
yield of pyridine loss – an analogue for the nitrile ligand – increasing from <0.0001 to 0.16 at 
500 nm when comparing Bpy and Mebpy compounds respectively.[16] Because Mebpy is a 
larger, more restricted ligand, the eg-like σ* orbitals decrease in energy due to reduced overlap, 
Bpy Mebpy 
1GS 3MC 1GS 3MC 
%Ru 
Character 
HOMO/LSOMO 76.10 8.62 76.25 10.77 
LUMO/HSOMO 6.11 38.15 5.54 38.09 
LUMO+1/LUMO 2.38 2.41 1.49 2.08 
%Tpy 
Character 
HOMO/LSOMO 13.05 89.84 14.20 86.94 
LUMO/HSOMO 93.01 8.51 89.51 9.50 
LUMO+1/LUMO 26.54 49.93 77.76 50.47 
OTOpy OTSpy 
1GS 3MC 1GS 3MC 
%Ru 
Character 
HOMO/LSOMO 72.22 69.38 73.01 67.68 
LUMO/HSOMO 6.55 43.24 4.86 43.31 
LUMO+1/LUMO 1.20 2.47 1.23 2.22 
%Tpy 
Character 
HOMO/LSOMO 14.26 20.42 15.17 18.85 
LUMO/HSOMO 92.39 53.25 92.89 52.48 
LUMO+1/LUMO 98.38 97.13 98.40 96.98 
Acpy Thiopy 
1GS 3MC 1GS 3MC 
%Ru 
Character 
HOMO/LSOMO 75.99 31.27 70.94 65.36 
LUMO/HSOMO 7.99 39.21 5.00 45.20 
LUMO+1/LUMO 1.33 3.17 1.19 2.79 
%Tpy 
Character 
HOMO/LSOMO 8.38 62.60 15.14 18.44 
LUMO/HSOMO 90.54 54.24 91.42 52.90 
LUMO+1/LUMO 98.09 47.56 96.38 96.42 
making them more energetically accessible. Given this trend, the OTOpy and Thiopy complexes 
should yield more rapid ligand loss than the OTSpy and Acpy analogues.  
 
To confirm these computational studies, further practical experiments, such as the determination 
of excited state lifetimes and the quantum yield of ligand loss, are currently underway to assess 
the rate of ligand elimination for these compounds. Additional parameters such as density-
gradient densities, Mulliken spin densities, and π-backbonding are also being investigated to 
establish their impact on nitrile ligand loss efficiency. It is expected that complexes with greater 
degrees of π-backbonding and more disparity in the densities will achieve more efficient nitrile 
ligand loss.  
 
Conclusions 
[Ru(tpy)(bpy)(NCCH3)]2+, [Ru(tpy)(Mebpy)(NCCH3)]2+, [Ru(tpy)(OTOpy)(NCCH3)]2+, 
[Ru(tpy)(OTSpy)(NCCH3)]2+, [Ru(tpy)(Acpy)(NCCH3)]+, and [Ru(tpy)(Thiopy)(NCCH3)]2+ 
were investigated to determine which parameters most account for efficient nitrile ligand loss. It 
was determined that increased 3MC character, which is responsible for efficient nitrile ligand 
loss, was seen in [Ru(tpy)(Mebpy)(NCCH3)]2+, [Ru(tpy)(OTOpy)(NCCH3)]2+, and 
[Ru(tpy)(Thiopy)(NCCH3)]2+. Further studies are underway to affirm these assertions and 
explore other parameters, leading to a cohesive process for the rational design of PDT agents.  
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